隆基綠能(601012.SH):半年度報吿披露時間延期至8月31日
格隆匯8月29日丨隆基綠能(601012.SH)公佈,原計劃於2024年8月30日披露《2024年半年度報吿》。根據半年度報吿相關工作安排,公司將《2024年半年度報吿》披露時間延期至2024年8月31日,敬請投資者注意。公司半年度業績説明會召開時間不變,仍為2024年9月2日10:00-11:00。公司已於2024年7月10日披露《2024年半年度業績預吿》,公司業績情況在預吿範圍內,生產經營正常,不存在《上海證券交易所股票上市規則》等相關法律、法規和規範性文件中所規定的應披露而未披露的事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.